NEW YORK, March 26, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.
Spectrum Brands Legacy, Inc. (f/k/a Spectrum Brands Holdings, Inc.) (NYSE: SPB)
Class Period: June 14, 2016 - April 25, 2018
Lead Plaintiff Deadline: May 6, 2019
Join the action: https://www.zlk.com/pslra-1/spectrum-brands-holdings-inc-loss-form?wire=3
The lawsuit alleges: Spectrum Brands Legacy, Inc. (f/k/a Spectrum Brands Holdings, Inc.) made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (i) Spectrum had been self-inflicting the operational issues at its Ohio and Kansas facilities; (ii) these operational issues were, in fact, recurring in nature; (iii) these operational issues would continuously impact production, shipping levels and sales; and (iv) as a result of the foregoing, the Company’s financial statements were materially false and misleading at all relevant times.
To learn more about the Spectrum Brands Legacy, Inc. (f/k/a Spectrum Brands Holdings, Inc.) class action contact jlevi@levikorsinsky.com.
Stamps.com Inc. (NASDAQ: STMP)
Class Period: May 3, 2017 - February 21, 2019
Lead Plaintiff Deadline: April 29, 2019
Join the action: https://www.zlk.com/pslra-1/stamps-com-inc-loss-form?wire=3
The lawsuit alleges: Stamps.com Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Company’s financial results depended on the manipulation of a USPS program that cost USPS an estimated $235 million per year; and (ii) as a result, the Company’s business was unsustainable and its financial results were highly misleading.
To learn more about the Stamps.com Inc. class action contact jlevi@levikorsinsky.com.
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA)
Class Period: November 4, 2015 - February 11, 2019
Lead Plaintiff Deadline: April 26, 2019
Join the action: https://www.zlk.com/pslra-1/vanda-pharmaceuticals-inc-loss-form?wire=3
The lawsuit alleges: Vanda Pharmaceuticals Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (1) Vanda was engaged in a fraudulent scheme in which it promoted the off-label use of Fanapt and Hetlioz; (2) Vanda was fraudulently receiving drug reimbursements from the government by abusing Medicare, Medicaid, and Tricare programs; (3) as a result of the scheme, Vanda faced legal action from the government; (4) Vanda’s promotional materials for Fanapt and Hetlioz were false and misleading, garnering regulatory scrutiny from the U.S. Food and Drug Administration; and (5) as a result, defendants’ statements about Vanda’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
To learn more about the Vanda Pharmaceuticals Inc. class action contact jlevi@levikorsinsky.com.
Syneos Health, Inc. (NASDAQ: SYNH)
Class Period: May 10, 2017 - February 27, 2019
Lead Plaintiff Deadline: April 30, 2019
Join the action: https://www.zlk.com/pslra-1/syneos-health-inc-loss-form?wire=3
The lawsuit alleges that, during the class period, Syneos Health, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Syneos Health’s internal control over financial reporting was inadequate; (2) concerns regarding Syneos Health’s internal control over financial reporting would result in heightened regulatory scrutiny and an SEC investigation into the company’s revenue accounting policies, internal controls and related matters; and (3) as a result, defendants’ statements about Syneos Health’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.
To learn more about the Syneos Health, Inc. class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com